"Innovation in Medtech: Bedside to Bench to Bedside"
MEDx will be welcoming William A. Hawkins III, E'76 for the MEDx Annual Distinguished Lecture Series. This event, taking place at the Trent Semans Center for Health Education in the Great Hall, is open to the Duke community and a reception will follow. The lecture is from 4-5pm on Monday, October 02, 2017.
Mr. Hawkins is the Former Chairman and CEO of Medtronic and is currently advising Private Equity and Venture Capital groups as well as serving on multiple for-profit and non-profit boards. He was recently elected to the National Academy of Engineering and is an AIMBE Fellow.
Mr. Hawkins was President and CEO of Immucor from Oct 2011 to July 2015. Prior to Immucor, Mr. Hawkins served as Chairman and CEO of Medtronic, one of the world's largest and most innovative medical technology companies. Mr. Hawkins assumed the role of CEO in 2007 and became Chairman of the Board in 2008. He joined Medtronic in 2002 as SVP and President of Medtronic Vascular. He served in that role until June 2004. From 2004 until August 2007 he was President and Chief Operating Officer of Medtronic.
Prior to Medtronic, Mr. Hawkins served as President and Chief Executive Officer of Novoste Corp. Nasdaq (NOVT) and held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corp., and Eli Lilly & Co. He began his medical technology career with Carolina Medical Electronics in 1977.
Mr. Hawkins received his bachelor's degree in electrical and biomedical engineering from Duke in 1976, where he also conducted medical research in pathology. He then went on to earn an M.B.A. from the Darden School of Business, University of Virginia, in 1982.
Mr. Hawkins is a Senior Advisor to EW Healthcare Partners. He serves as a Director of Halyard Health NYSE:HYH and Chairman of the Board of KeraNetics and of Bioventus. He is Lead Director at Immucor and serves on the Board of Trice Medical, Virtue Labs and Baebies. Mr. Hawkins is the Past Chairman and co-Founder of the Medical Device Innovation Consortium ("MDIC"), and past-president of the American Institute of Medical and Biological Engineering ("AMIBE"). He recently joined the board of the Focused Ultrasound Society. Mr. Hawkins was elected to the Duke University Board of Trustees in 2011 and currently serves on the Executive Committee as the Vice Chair of the Board. He is on the Audit, Risk and Compliance Committee, and he Chairs the Business and Finance Committee. Mr. Hawkins is also Vice Chair of the Board of the Duke University Health System.
Mr. Hawkins also serves as a Member of the Advisory Boards at Arboretum Ventures, HealthQuest Ventures, Accuitive Medical Ventures, A*STAR SERC Cluster Advisory Board in Singapore, and the Biomedical Research Council of Singapore.